These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15726711)

  • 1. Assessing glaucoma's risk factors. During initial screening, signs of damage to the optic nerve could be more reliable indicators of the disease.
    Health News; 2005 Jan; 11(1):10-1. PubMed ID: 15726711
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improving management of glaucoma's risk factors].
    Sellem E
    J Fr Ophtalmol; 2009 Mar; 32(3):203-5. PubMed ID: 19515334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glaucoma: a preventable cause of blindness.
    Higginbotham EJ
    Md Med J; 1997 Sep; 46(8):412-4. PubMed ID: 9294947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glaucoma's optic nerve damage: changing clinical perspectives.
    Quigley HA
    Ann Ophthalmol; 1982 Jul; 14(7):611-2. PubMed ID: 7125449
    [No Abstract]   [Full Text] [Related]  

  • 5. Glaucoma update--what physicians and the public need to know.
    Sim DH
    Singapore Med J; 1999 Apr; 40(4):317-20. PubMed ID: 10487093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing vision loss from glaucoma: putting data from clinical trials into practice.
    Schoenleber DB
    Mo Med; 2005; 102(1):51-4. PubMed ID: 15754618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
    Schwartz M; London A
    Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving global risk assessment of ocular hypertension to glaucoma.
    Fechtner RD; Khouri AS
    Curr Opin Ophthalmol; 2007 Mar; 18(2):104-9. PubMed ID: 17301610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical discussion of the rates of progression and causes of optic nerve damage in glaucoma: International Glaucoma Think Tank II: July 25-26, 2008, Florence, Italy.
    Caprioli J; Zeyen T
    J Glaucoma; 2009 Aug; 18(6 Suppl):S1-21. PubMed ID: 19680047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the visual burden of glaucoma in Asia: what we know and what we need to know.
    Congdon N
    J Glaucoma; 2009 Jan; 18(1):88-92. PubMed ID: 19142142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucoma screening: current trends, economic issues, technology, and challenges.
    Nduaguba C; Lee RK
    Curr Opin Ophthalmol; 2006 Apr; 17(2):142-52. PubMed ID: 16552249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glaucoma as a disease of social importance].
    Aliquo'-Mazzei A
    Friuli Med; 1968; 23(2):297-327. PubMed ID: 5747404
    [No Abstract]   [Full Text] [Related]  

  • 14. The PCP's role in chronic open-angle glaucoma.
    Lin AP; Orengo-Nania S; Braun UK
    Geriatrics; 2009 Jul; 64(7):20-8. PubMed ID: 19586087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparing applanation and impression tonometry in Central African Bantu people].
    Krüger H; Schittkowski MP; Guthoff RF
    Klin Monbl Augenheilkd; 2007 Sep; 224(9):722-6. PubMed ID: 17846962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angle closure glaucoma: a cause for bilateral visual threat.
    Shakya S; Gupta HR
    Nepal Med Coll J; 2006 Sep; 8(3):153-5. PubMed ID: 17203819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and open-angle glaucoma: classification and application.
    Boland MV; Quigley HA
    J Glaucoma; 2007; 16(4):406-18. PubMed ID: 17571004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oman Eye Study 2005: prevalence and determinants of glaucoma.
    Khandekar R; Jaffer MA; Al Raisi A; Zutshi R; Mahabaleshwar M; Shah R; Choudhury AH
    East Mediterr Health J; 2008; 14(6):1349-59. PubMed ID: 19161110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of ocular anterior chamber tissues to oxidative damage and its relevance to the pathogenesis of glaucoma.
    Izzotti A; Saccà SC; Longobardi M; Cartiglia C
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5251-8. PubMed ID: 19516005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.